![](/imager/uploads/Companies/Noetik/58794/2000_core_image_condensed_6439e647a38ed5b4d852739476ebaac9.webp)
![](/imager/uploads/Companies/Noetik/55490/Tumor-core-protein-example-5-1-1-2-copy_6439e647a38ed5b4d852739476ebaac9.webp)
![](/uploads/logos/_logo_h/noetik-logo-black.png)
AI is revolutionizing drug and therapeutics discovery, but the supervised learning approaches that have dominated up to now — which depend on data labeled by human experts — aren’t scalable. Noetik is generating the hundreds of terabytes of genomic, transcriptomic, and proteomic data on cells and tissues that will be needed to power self-supervised, transformer-based predictive modeling in the realm of cancer immunotherapy. The company’s platform helps identify novel targets for therapeutics and predicts how patients will respond.
News & Insights
Explore Companies
![](/imager/uploads/logos/58681/Avicenna_logo_black_117378e58441a39758ec294c229f7090.webp)
Avicenna Biosciences
Using AI to speed through the last mile of drug discovery
![](/imager/uploads/logos/58643/latus-logo-copy_117378e58441a39758ec294c229f7090.webp)
![](/imager/uploads/Companies/Latus/58650/Latus-lab_6439e647a38ed5b4d852739476ebaac9.webp)
Latus Bio
Finding precisely tuned viral vectors for gene therapy in CNS disorders
![](/imager/uploads/logos/57002/radionetics-logo_black_117378e58441a39758ec294c229f7090.webp)
![](/imager/uploads/Companies/Radionetics/57003/Radionetics_6439e647a38ed5b4d852739476ebaac9.webp)
Radionetics Oncology
Discovering more precise ways to deploy radiopharmaceuticals against solid tumors
![](/imager/uploads/logos/55895/DVLP-logo-black_117378e58441a39758ec294c229f7090.webp)
DVLP Medicines
Creating a software co-pilot for drug development and a new marketplace for investors and outsourced R&D and manufacturing